Jonathan Stine

Has grant

Associate Professor of Medicine and Public Health Sciences

Penn State Health Milton S Hershey Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Nonalcoholic steatohepatitis fitness intervention for thrombosis (NASHFit) Trial

Open Date: 2018-07-01

Close Date: 2020-06-01

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (7)

Shelley E. Keating

AUSTRALIA

View details

Vernon Chinchilli

Distinguished Professor

Penn State College of Medicine

UNITED STATES

View details

Angelo Sabag

University of Sydney

AUSTRALIA

View details

Scot Kimball

Professor

Penn State College of Medicine

UNITED STATES

View details

A. Margot Umpleby

Professor

University of Surrey

UNITED KINGDOM

View details

Christopher Pugh

Cardiff University

UNITED KINGDOM

View details

Stefano Romeo

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jonathan Stine

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (16)

Exercise improves surrogate measures of liver histological response in metabolic dysfunction‐associated steatotic liver disease

Frailty in liver transplantation: Exploring prescribing exercise as medicine to improve patient outcomes

Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction–associated steatotic liver disease: A systematic review and meta-analysis

AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise training

Editorial: Enhancing frailty assessment in liver transplantation candidates—The role of the Duke Activity Status Index in predicting mortality and guiding prehabilitation

Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction‐associated steatohepatitis

(P)rehabilitation in advanced chronic liver disease (advCLD): From basic exercise concepts to implementation challenges

Serum Fibroblast Growth Factor 21 Is Markedly Decreased following Exercise Training in Patients with Biopsy-Proven Nonalcoholic Steatohepatitis

Sweating it out: How physical activity can combat high genetic risk for nonalcoholic fatty liver disease

Unlocking metabolic flexibility: Is this the key to preventing weight gain in liver transplant recipients?

Exercise Training Is Associated With Treatment Response in Liver Fat Content by Magnetic Resonance Imaging Independent of Clinically Significant Body Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness

Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms

Editorial: let's get physical—long‐term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease

Magnetic resonance imaging proton density fat fraction as an imaging‐based biomarker of treatment response in patients with nonalcoholic steatohepatitis

NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH

Collaborators (7)

Shelley E. Keating

Vernon Chinchilli

Angelo Sabag

Scot Kimball

A. Margot Umpleby

Christopher Pugh

Stefano Romeo

Make your next move.